Skip to main content

Retraction Note: Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway

The Original Article was published on 03 January 2020

Retraction Note: Stem Cell Research & Therapy (2020) 11:2

The Editors-in-Chief have retracted this article after concerns were raised about potential image re-use between Fig. 4D and 5D and the potential partial overlap between Fig. 6A and Supplementary Fig. 4A. The authors were unable to provide raw data for Figs. 4 and 5. The raw images provided for Fig. 6A and Supplementary Fig. 4A contained further partial image overlaps between different experimental conditions. The authors were also unable to share evidence of ethics approval. Therefore, the Editors have lost confidence in the data presented here.

Yuanlin Song agrees to this retraction. Yun Feng and Xiaotong Yang do not agree to this retraction. Linlin Wang, Xiaoying Ma, Ocholi Don, Xiaoyan Chen and Jieming Qu have not responded to any correspondence from the editor/publisher about this retraction.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Jieming Qu or Yuanlin Song.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, Y., Wang, L., Ma, X. et al. Retraction Note: Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway. Stem Cell Res Ther 14, 280 (2023).

Download citation

  • Published:

  • DOI: